LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 201 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,838 | -69.5% | 3,769 | -62.6% | 0.00% | -100.0% |
| Q1 2023 | $741,338 | -5.3% | 10,078 | -14.0% | 0.01% | -21.4% |
| Q4 2022 | $782,696 | +118.0% | 11,717 | +181.3% | 0.01% | +100.0% |
| Q3 2022 | $359,000 | -16.3% | 4,166 | -13.4% | 0.01% | -41.7% |
| Q2 2022 | $429,000 | -66.8% | 4,811 | -63.0% | 0.01% | -84.4% |
| Q3 2019 | $1,294,000 | -32.1% | 13,000 | -22.2% | 0.08% | -63.2% |
| Q2 2019 | $1,906,000 | – | 16,700 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |